A recent study in a rat model of connective tissue disease related pulmonary arterial hypertension (CTD-PAH) showed that knockdown of endocan attenuated the severity of PAH and related cardiac dysfunction, accompanied with the inhibition of tumor necrosis factor-α (TNF-α) signaling pathways [17]. This evidence concerns the gene ESM1 and pulmonary arterial hypertension.